DelAversano Robert J 4
4 · Grace Therapeutics, Inc. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
DelAversano Robert J
Principal Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-14+20,130→ 20,130 totalExercise: $2.08Exp: 2035-04-14→ Common Stock (20,130 underlying)
Footnotes (1)
- [F1]This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date.